Press release -
Growing number of Primary Immunodeficiency Diseases Treatment Market 2017-2021
About Primary Immunodeficiency Diseases Treatment
Primary immunodeficiency diseases or PIDDs are disorders where part of the body's immune system is missing or not functioning properly. They weaken the body's immune system, making the patient susceptible to infections and other health problems. Treatment is palliative and includes boosting the immune system, thereby helping the patient live a normal life. The major drug classes used for the treatment and management of the disease are immunoglobulins, antibiotics, and others.
Technavios analysts forecast the global primary immunodeficiency diseases treatment market to grow at a CAGR of 6.13% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global primary immunodeficiency diseases treatment market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
Technavio's report, Global Primary Immunodeficiency Diseases Treatment Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
CSL Behring
Grifols
Pfizer
Shire
Get Sample Copy Of This Report @https://www.marketresearchreports.biz/sample/sample/1377990
Other prominent vendors
Abbott
ADMA Biologics
Astellas
AstraZeneca
Baxter
Bayer
Biocon
Bristol-Myers Squibb
BDI Pharma
Bharat Serums and Vaccines
Eli Lilly
GlaxoSmithKline
Hualan Biological Engineering
Kedrion Biopharma
LFB Group
Lupin Pharmaceuticals
Mylan
Novartis
Octapharma
Sanofi
Sanquin
Takeda Pharmaceutical Company
Valneva
Wockhardt
Market driver
Growing number of fractionating units
For a full, detailed list, view our report
Market challenge
High cost of treatment
For a full, detailed list, view our report
Market trend
Shift of manufacturing facilities to low-cost regions
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
https://www.marketresearchreports.biz/sample/enquiry/1377990
Table of Contents
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
Market outline
PART 05: Market landscape
Market overview
Five forces analysis
PART 06: Pipeline landscape
PART 07: Market segmentation by therapy
Immunoglobulin therapy
Antibiotics
Others
PART 08: Geographical segmentation
PIDDs treatment market in Americas
PIDDs treatment market in EMEA
PIDDs treatment market in APAC
PART 09: Decision framework
PART 10: Drivers and challenges
Market drivers
Market challenges
PART 11: Market trends
Shift of manufacturing facilities to low-cost regions
Financial aid to plasma donors
PART 12: Vendor landscape
PART 13: Key vendor analysis
CSL Behring
Grifols
Pfizer
About us
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
Contact
Mr. Nachiketa
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074
Categories
- primary immunodeficiency diseases treatment
- market research reports